Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.

Kevin W McConeghyKwan HurIssa J DahabrehRong JiangLucy PandeyWalid F GelladPeter GlassmanChester B GoodDonald R MillerAndrew R ZulloStefan GravensteinFrancesca Cunningham

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

Vaccination against COVID-19 was associated with a lower but not statistically significantly different risk of death in the first 60 days. These results agree with prior scientific knowledge suggesting vaccination is safe with the potential for substantial health benefits.

Keyphrases

coronavirus disease
healthcare
sars cov
public health
clinical trial
respiratory syndrome coronavirus
study protocol
mental health
human health
randomized controlled trial
health information
phase iii
risk assessment
social media
open label
health promotion